[{"orgOrder":0,"company":"CD Pharma","sponsor":"Sree Mookambika Institute of Dental Sciences","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Antibiotic","year":"2014","type":"Inapplicable","leadProduct":"Inersan","moa":"Oral bacteria","graph1":"Dental and Oral Health","graph2":"Phase III","graph3":"CD Pharma","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"CD Pharma \/ Sree Mookambika Institute of Dental Sciences","highestDevelopmentStatusID":"10","companyTruncated":"CD Pharma \/ Sree Mookambika Institute of Dental Sciences"},{"orgOrder":0,"company":"CD Pharma","sponsor":"Mahatma Gandhi PGI Dental Sciences","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Undisclosed","year":"2013","type":"Inapplicable","leadProduct":"Lactobacillus Brevis CD2","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase III","graph3":"CD Pharma","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Troche\/Lozenge","sponsorNew":"CD Pharma \/ Mahatma Gandhi PGI Dental Sciences","highestDevelopmentStatusID":"10","companyTruncated":"CD Pharma \/ Mahatma Gandhi PGI Dental Sciences"},{"orgOrder":0,"company":"CD Pharma","sponsor":"Government Dental College and Hospital, India","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Undisclosed","year":"2014","type":"Inapplicable","leadProduct":"Lactobacillus Brevis CD2","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase III","graph3":"CD Pharma","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Troche\/Lozenge","sponsorNew":"CD Pharma \/ Government Dental College and Hospital, India","highestDevelopmentStatusID":"10","companyTruncated":"CD Pharma \/ Government Dental College and Hospital, India"},{"orgOrder":0,"company":"CD Pharma","sponsor":"Government Dental College and Hospital, Vijayawada, Andra Pradesh, India","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Undisclosed","year":"2014","type":"Inapplicable","leadProduct":"Lactobacillus Brevis CD2","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase III","graph3":"CD Pharma","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Troche\/Lozenge","sponsorNew":"CD Pharma \/ Government Dental College and Hospital, Vijayawada, Andra Pradesh, India","highestDevelopmentStatusID":"10","companyTruncated":"CD Pharma \/ Government Dental College and Hospital, Vijayawada, Andra Pradesh, India"},{"orgOrder":0,"company":"CD Pharma","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"INDIA","productType":"Probiotic","year":"2010","type":"Inapplicable","leadProduct":"Lactobacillus Paracasei","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase II\/ Phase III","graph3":"CD Pharma","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"CD Pharma \/ Post Graduate Institute of Medical Education and Research, Chandigarh","highestDevelopmentStatusID":"9","companyTruncated":"CD Pharma \/ Post Graduate Institute of Medical Education and Research, Chandigarh"}]

Find Clinical Drug Pipeline Developments & Deals by CD Pharma

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          AIChE Annual Meeting
                          Not Confirmed
                          AIChE Annual Meeting
                          Not Confirmed

                          Lead Product(s) : Lactobacillus Brevis CD2

                          Therapeutic Area : Dental and Oral Health

                          Study Phase : Phase III

                          Sponsor : Government Dental College and Hospital, Vijayawada, Andra Pradesh, India

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Lactobacillus Brevis CD2 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Periodontitis.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          July 30, 2014

                          Lead Product(s) : Lactobacillus Brevis CD2

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase III

                          Sponsor : Government Dental College and Hospital, Vijayawada, Andra Pradesh, India

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          AIChE Annual Meeting
                          Not Confirmed
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : Inersan is a Antibiotic drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Chronic Periodontitis.

                          Product Name : Undisclosed

                          Product Type : Antibiotic

                          Upfront Cash : Inapplicable

                          June 26, 2014

                          Lead Product(s) : Inersan

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase III

                          Sponsor : Sree Mookambika Institute of Dental Sciences

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          AIChE Annual Meeting
                          Not Confirmed
                          AIChE Annual Meeting
                          Not Confirmed

                          Lead Product(s) : Lactobacillus Brevis CD2

                          Therapeutic Area : Dental and Oral Health

                          Study Phase : Phase III

                          Sponsor : Government Dental College and Hospital, India

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Lactobacillus Brevis CD2 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Chronic Periodontitis.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          April 23, 2014

                          Lead Product(s) : Lactobacillus Brevis CD2

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase III

                          Sponsor : Government Dental College and Hospital, India

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          AIChE Annual Meeting
                          Not Confirmed
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : Lactobacillus Brevis CD2 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Chronic Periodontitis.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          June 06, 2013

                          Lead Product(s) : Lactobacillus Brevis CD2

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase III

                          Sponsor : Mahatma Gandhi PGI Dental Sciences

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          AIChE Annual Meeting
                          Not Confirmed
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : Lactobacillus Paracasei is a Probiotic drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Hepatic Encephalopathy.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          April 26, 2010

                          Lead Product(s) : Lactobacillus Paracasei

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Post Graduate Institute of Medical Education and Research, Chandigarh

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank